发明名称 COMPUESTOS DERIVADOS DE OXIMILO MACROCICLICO, INHIBIDORES DE PROTEASA DE HEPATITIS C; COMPOSICION FARMACEUTICA, UTIL PARA EL TRATAMIENTO DE INFECCION POR HEPATITIS C.
摘要 The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
申请公布号 CL2007001629(A1) 申请公布日期 2008.02.08
申请号 CL20070001629 申请日期 2007.06.06
申请人 ENANTA PHARMACEUTICALS, INC. 发明人 YING SUN, DEQIANG NIU, GUOYOU XU, YAT SUN OR, ZHEWANG.
分类号 A61K38/06;A61P31/14;C07K5/08 主分类号 A61K38/06
代理机构 代理人
主权项
地址